Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring demand for its Wegovy obesity drugs.
Novo Nordisk posts net profit beat on Wegovy sales jump, sees growth slowdown this year
Related Posts
Trump 2.0 could go ‘nuclear’ on China trade, while economists say Harris would remain tough
Economists and trade experts largely expect Trump would further cut and destabilize trade relations between the world’s two largest economies.
US brings man mistakenly deported to El Salvador back to face charges
Salvadoran Kilmar Ábrego García, whose case became a political flashpoint, has been charged with human trafficking by US officials.
Optimizing LLM Reasoning: Balancing Internal Knowledge and Tool Use with SMART
Recent advancements in LLMs have significantly improved their reasoning abilities, enabling them to perform text composition, code generation, and logical…